Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial

BACKGROUND: COIN compared first-line continuous chemotherapy with the same chemotherapy given intermittently or with cetuximab in advanced colorectal cancer (aCRC). METHODS: Choice between oxaliplatin/capecitabine (OxCap) and oxaliplatin/leucovorin (LV)/infusional 5-FU (OxFU) was by physician and pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Madi, A, Fisher, D, Wilson, R H, Adams, R A, Meade, A M, Kenny, S L, Nichols, L L, Seymour, M T, Wasan, H, Kaplan, R, Maughan, T S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461171/
https://www.ncbi.nlm.nih.gov/pubmed/22935584
http://dx.doi.org/10.1038/bjc.2012.384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461171/
https://www.ncbi.nlm.nih.gov/pubmed/22935584
http://dx.doi.org/10.1038/bjc.2012.384

Ejemplares similares